Closed-Loop Insulin Pumps Show Promise for Managing Type 1 Diabetes in Pregnancy

Pregnancy brings unique challenges for women with type 1 diabetes. During pregnancy, maintaining tight blood sugar control is critical—not just for the mother's health, but for the developing baby as well. Research shows that high blood sugar (hyperglycemia) complications occur in about 50% of pregnant women with type 1 diabetes. These complications can affect both mother and baby, which is why pregnancy-specific blood sugar targets are narrower than they are outside of pregnancy.

Before and during pregnancy, achieving strict glycemic goals has been shown to reduce the risk of birth defects and other serious pregnancy complications. Yet many women with type 1 diabetes do not receive the specialized preconception care that can help them reach these targets. This gap between what research recommends and what happens in real-world practice highlights why new tools that make blood sugar management easier matter.

A new international trial called CIRCUIT tested whether closed-loop insulin systems could help pregnant women with type 1 diabetes achieve better blood sugar control. The study included 88 women with type 1 diabetes at clinical centers in Canada and Australia, enrolled before 14 weeks of pregnancy and followed through six weeks after delivery.

Women were randomly assigned to use either a closed-loop insulin system paired with continuous glucose monitoring, or standard care (an insulin pump or multiple daily injections, also with continuous glucose monitoring). Researchers measured how much time each group spent in the pregnancy-specific safe blood sugar range of 63-140 mg/dL between weeks 16 and 34 of pregnancy.

The results showed a meaningful difference: women using the closed-loop system spent 65% of their time in the target range, compared to 50% in the standard care group. In practical terms, that means the closed-loop group spent about 2.5 more hours per day in the safer blood sugar zone. The closed-loop group also had fewer episodes of severe low blood sugar and diabetic ketoacidosis, though serious events were rare in both groups.

A closed-loop insulin system, sometimes called an 'artificial pancreas,' automates part of the work of managing blood sugar. The system uses a continuous glucose monitor to measure blood sugar levels throughout the day and night, and an insulin pump that delivers insulin. An algorithm—a set of programmed instructions—reads the glucose readings and adjusts insulin delivery automatically, without the person having to manually calculate and enter doses.

Diabetes technology overall has expanded significantly in recent years. Beyond closed-loop systems, tools like continuous glucose monitors, connected insulin pens, and traditional insulin pumps have all been shown to ease the burden of daily diabetes management, improve blood sugar control, and boost quality of life for people with type 1 diabetes. The CIRCUIT trial adapted closed-loop technology specifically for the unique demands of pregnancy, with blood sugar targets adjusted to keep both mother and baby safer.

The CIRCUIT trial provides solid evidence that closed-loop systems can help pregnant women with type 1 diabetes achieve tighter blood sugar control during the critical months of pregnancy. However, this was a single trial, and more research is needed to confirm these findings, understand long-term outcomes, and determine who benefits most from this technology.

If you are pregnant or planning to become pregnant with type 1 diabetes, this research supports talking with your healthcare team about all available tools to manage your blood sugar—including closed-loop systems if they are available to you. Preconception care and optimizing blood sugar control before conception remains essential, and your care team can help you create a management plan tailored to your needs. This is not a do-it-yourself decision; personalized guidance from diabetes specialists and obstetric providers is important for the best outcomes.

Origin: YouTube / Juicebox Podcast (Video report). Evidence: Video report, corroborated with 5 indexed studies. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.